Role of α2‐macroglobulin in regulating amyloid β‐protein neurotoxicity: protective or detrimental factor?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Neurochemistry

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.1471-4159.2001.00419.X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease

  2012cited by this paper
• Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

  2000cited by this paper
• A Protective Role of the Low Density Lipoprotein Receptor-related Protein against Amyloid β-Protein Toxicity*

  2000cited by this paper
• Modulation of β-Amyloid Precursor Protein Processing by the Low Density Lipoprotein Receptor-related Protein (LRP)

  2000cited by this paper
• LRP in Alzheimer's disease: friend or foe?

  2000cited by this paper
• Association between coding variability in the LRP gene and the risk of late-onset Alzheimer’s disease

  1999cited by this paper
• Rat α2‐macroglobulin inhibits NGF‐promoted neurite outgrowth, TrK phosphorylation, and gene expression of pheochromocytoma PC12 cells

  1999cited by this paper
• α2‐Macroglobulin Enhances the Clearance of Endogenous Soluble β‐Amyloid Peptide via Low‐Density Lipoprotein Receptor‐Related Protein in Cortical Neuron

  1999cited by this paper
• Aberrant presenilin-1 expression downregulates LDL receptor-related protein (LRP): is LRP central to Alzheimer's disease pathogenesis?

  1999cited by this paper
• Activated α2Macroglobulin Increases β-Amyloid (25–35)-Induced Toxicity in LAN5 Human Neuroblastoma Cells

  1999cited by this paper
• Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner.

  1999cited by this paper
• Alpha-2 macroglobulin is genetically associated with Alzheimer disease

  1998cited by this paper
• Localization of the Binding Site for Transforming Growth Factor-β in Human α2-Macroglobulin to a 20-kDa Peptide That Also Contains the Bait Region*

  1998cited by this paper
• α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation

  1998cited by this paper
• Transforming growth factor-β inhibits apoptosis induced by β-amyloid peptide fragment 25–35 in cultured neuronal cells

  1998cited by this paper
• Modulation of the alpha 2 macroglobulin receptor/low density lipoprotein receptor related protein by interferon-gamma in human astroglial cells.

  1997cited by this paper
• Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.

  1997cited by this paper
• Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons.

  1996cited by this paper
• LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation.

  1995cited by this paper
• Multiple, diverse senile plaque–associated proteins are ligands of an apolipoprotein e receptor, the α2‐macroglobulin receptor/low‐density‐lipoprotein receptor—related protein

  1995cited by this paper
• Increased serum α1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response

  1995cited by this paper
• Expression of the α2-macroglobulin-encoding gene in rat brain and cultured astrocytes

  1994cited by this paper
• The kinetics of conformational changes of α2‐macroglobulin determined by time resolved X‐ray solution scattering

  1994cited by this paper
• α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease

  1993cited by this paper
• Surface expression of the α2-macroglobulin receptor on human malignant blood cells☆

  1992cited by this paper
• Age-related changes in cerebrospinal fluid protein concentrations.

  1991cited by this paper
• Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

  1991cited by this paper
• Immunoelectron microscopy studies with a monoclonal antibody directed against a receptor recognition site epitope in human alpha 2-macroglobulin.

  1991cited by this paper
• Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

  1989cited by this paper
• Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.

  1987cited by this paper
• Characterization of human neuroblastoma cell lines established before and after therapy.

  1986cited by this paper
• Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.

  1985cited by this paper
• Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.

  1984cited by this paper
• Neuroblastoma cells produce transforming growth factors during exponential growth in a defined hormone-free medium.

  1984cited by this paper
• Evidence for similar conformational changes in alpha 2-macroglobulin on reaction with primary amines or proteolytic enzymes.

  1982cited by this paper
• Phenotypic changes of human neuroblastoma cells in culture induced by 12‐O‐tetradecanoyl‐phorbol‐13‐acetate

  1981cited by this paper
• [54] α2-Macroglobulin

  1981cited by this paper

• Neuroinflammation as a factor of pathogenesis of glaucomatous optic neuropathy

  2024cites this paper
• Multifunctional Protein Alpha2-Macroglobulin in Tear Fluid and Blood Serum of Patients with Glaucoma

  2023cites this paper
• Induced forms of α2-macroglobulin neutralize heparin and direct oral anticoagulant effects.

  2021cites this paper
• Alpha-2-Macroglobulin, a Hypochlorite-Regulated Chaperone and Immune System Modulator

  2019cites this paper
• Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers

  2018cites this paper
• Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?

  2017cites this paper
• p75NTR antagonists attenuate photoreceptor cell loss in murine models of retinitis pigmentosa

  2017cites this paper
• Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

  2017cites this paper
• Purification, Characterization and Studies on Sheep Alpha-2- Macroglobulin

  2016influential citation
• Proteomic investigation of blood-based biomarkers for the diagnosis of HIV-associated neurocognitive disorders

  2015cites this paper
• A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo

  2015cites this paper
• Alpha-2-Macroglobulin Is Acutely Sensitive to Freezing and Lyophilization: Implications for Structural and Functional Studies

  2015cites this paper
• The Role of proteases and chaperones in extracellular proteostasis

  2015cites this paper
• Interactions between Apo E and amyloid beta and their relationship to nutriproteomics and neurodegeneration

  2014cites this paper
• Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms

  2013cites this paper
• Alpha‐2‐macroglobulin: A physiological guardian

  2013cites this paper
• Extracellular chaperones and proteostasis.

  2013cites this paper
• Extracellular chaperones prevent Aβ42-induced toxicity in rat brains.

  2013cites this paper
• Early-forming aberrant aggregates in protein deposition diseases: structural characteristics, interaction with molecular chaperones, ability to trigger inflammation

  2013cites this paper
• Fibrinogen chaperone activity in Transthyretin Amyloidosis: The effect of protein glycation

  2012cites this paper
• Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers

  2012cites this paper
• BRICHOS Domains Efficiently Delay Fibrillation of Amyloid β-Peptide*

  2012cites this paper
• Efficacy of Multifunctionalized Saccharide Constructs for the Attenuation of Amyloid-beta Toxicity

  2012influential citation
• Roles of extracellular chaperones in amyloidosis.

  2012cites this paper
• Phagocytic clearance in neurodegeneration.

  2011cites this paper
• alpha2-Macroglobulin induces glial fibrillary acidic protein expression mediated by low-density lipoprotein receptor-related protein 1 in Müller cells.

  2011cites this paper
• Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

  2010cites this paper
• Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome.

  2010cites this paper
• The role of clusterin (CLU) in extracellular protein folding quality control.

  2009cites this paper
• Extracellular chaperones modulate the effects of Alzheimer’s patient cerebrospinal fluid on Aβ1-42 toxicity and uptake

  2009cites this paper
• Chapter 6: The chaperone action of Clusterin and its putative role in quality control of extracellular protein folding.

  2009cites this paper
• α2-Macroglobulin and Haptoglobin Suppress Amyloid Formation by Interacting with Prefibrillar Protein Species*

  2009cites this paper
• Trypanosoma cruzi: alpha-2-macroglobulin regulates host cell apoptosis induced by the parasite infection in vitro.

  2008cites this paper
• Alpha-2-Macroglobulin: an abundant extracellular chaperone

  2008cites this paper
• Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity.

  2008cites this paper
• α2-Macroglobulin Is a Mediator of Retinal Ganglion Cell Death in Glaucoma*

  2008cites this paper
• Extracellular Chaperones and Amyloids

  2008cites this paper
• Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.

  2008cites this paper
• Proteases and lipoprotein receptors in Alzheimer's disease

  2007cites this paper
• Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.

  2007cites this paper
• The genetic association between alpha-2-macroglobulin (A 2 M) gene deletion polymorphism and low serum A 2 M concentration in overweight/obese Thais

  2006cites this paper
• S100B protects LAN‐5 neuroblastoma cells against Aβ amyloid‐induced neurotoxicity via RAGE engagement at low doses but increases Aβ amyloid neurotoxicity at high doses

  2006cites this paper
• Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus.

  2006cites this paper
• Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells.

  2005cites this paper
• A chemically modified preparation of α2‐macroglobulin binds β‐amyloid peptide with increased affinity and inhibits Aβ cytotoxicity

  2005cites this paper
• Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer

  2004cites this paper
• Proteomic analysis of adipocyte differentiation: Evidence that α2 macroglobulin is involved in the adipose conversion of 3T3 L1 preadipocytes

  2004cites this paper
• Identification of the human cDNA for new survival/evasion peptide (DSEP): studies in vitro and in vivo of overexpression by neural cells.

  2002cites this paper